Why geneticists stole cancer research even though cancer is primarily a signaling disease
- 22 January 2019
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 12 (565) , eaaw3483
Abstract
Technological advances in protein detection will enable breakthroughs in precision cancer medicine.Keywords
Funding Information
- NIH Office of the Director (ES-015339)
- Ovarian Cancer Research Fund
- MIT Center for Precision Cancer Medicine
This publication has 9 references indexed in Scilit:
- Illuminating the dark phosphoproteomeScience Signaling, 2019
- Mutational processes shape the landscape of TP53 mutations in human cancerNature Genetics, 2018
- Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded AntibodiesMolecular & Cellular Proteomics, 2018
- Analysis of aptamer discovery and technologyNature Reviews Chemistry, 2017
- Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcodingScientific Reports, 2017
- Mass Cytometry: Single Cells, Many FeaturesCell, 2016
- Multiplexed Epitope-Based Tissue Imaging for Discovery and Healthcare ApplicationsCell Systems, 2016
- Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impactExpert Review of Proteomics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011